These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10597225)

  • 1. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing of t(2;7) translocations reveals a consistent breakpoint linking CDK6 to the IGK locus in indolent B-cell neoplasia.
    Parker EP; Siebert R; Oo TH; Schneider D; Hayette S; Wang C
    J Mol Diagn; 2013 Jan; 15(1):101-9. PubMed ID: 23127611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.
    Brito-Babapulle V; Gruszka-Westwood AM; Platt G; Andersen CL; Elnenaei MO; Matutes E; Wotherspoon AC; Weston-Smith SG; Catovsky D
    Haematologica; 2002 Apr; 87(4):357-62. PubMed ID: 11940479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
    Parker E; Macdonald JR; Wang C
    Cancer Genet; 2011 May; 204(5):260-4. PubMed ID: 21665179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
    Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.
    Douet-Guilbert N; Tous C; Le Flahec G; Bovo C; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
    Cancer Genet; 2014 Mar; 207(3):83-6. PubMed ID: 24726269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma.
    Batanian JR; Dunphy CH; Richart JM; Petruska PJ; Perkins SL
    Cancer Genet Cytogenet; 2000 Jul; 120(2):136-40. PubMed ID: 10942804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci.
    Martín-Subero JI; Harder L; Gesk S; Schlegelberger B; Grote W; Martinez-Climent JA; Dyer MJ; Novo FJ; Calasanz MJ; Siebert R
    Int J Cancer; 2002 Mar; 98(3):470-4. PubMed ID: 11920602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
    Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
    Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 15. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
    Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
    PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
    Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
    Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
    Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
    Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
    Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.
    Remstein ED; James CD; Kurtin PJ
    Am J Pathol; 2000 Apr; 156(4):1183-8. PubMed ID: 10751343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.